Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?

There's a good reason why AstraZeneca tanked when merger rumors hit the Street.

CryptoAlerta — análise de criptomoedas e mercado em tempo real